Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204693682> ?p ?o ?g. }
- W3204693682 endingPage "564" @default.
- W3204693682 startingPage "553" @default.
- W3204693682 abstract "Antimicrobial resistance (AMR) is an emerging global threat. It increases mortality and morbidity and strains healthcare systems. Health care professionals can counter the rising AMR by promoting antibiotic stewardship and facilitating new drug development. Even with the economic and scientific challenges, it is reassuring that new agents continue to be developed.This review addresses new antibiotics in the pipeline. We conducted a review of the literature including Medline, Clinicaltrials.org, and relevant pharmaceutical companies for approved and in pipeline antibiotics in phase 3 or new drug application (NDA).We found a number of new antibiotics and reviewed their current development status, mode of action, spectra of activity, and indications for which they have been approved. The included studies from phase 3 clinical trials were mainly utilized for the treatment of acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, and pneumonia acquired in the healthcare settings. The number of these agents is limited against high priority organisms. The identified antibiotics were based mainly on previously known molecules or pre-existing antimicrobial agents.There are a limited number of antibiotics against high priority organisms such as multi-drug-resistant Pseudomonas aeruginosa, and carbapenem-resistant Enterobacteriaceae. New antimicrobial agents directed against the top priority organisms as classified by the World Health Organization are urgently needed." @default.
- W3204693682 created "2021-10-11" @default.
- W3204693682 creator A5004324358 @default.
- W3204693682 creator A5014593593 @default.
- W3204693682 creator A5014988046 @default.
- W3204693682 creator A5020602200 @default.
- W3204693682 creator A5022201674 @default.
- W3204693682 creator A5037175619 @default.
- W3204693682 creator A5042021657 @default.
- W3204693682 creator A5052996857 @default.
- W3204693682 creator A5060847041 @default.
- W3204693682 creator A5079725698 @default.
- W3204693682 creator A5091810265 @default.
- W3204693682 date "2021-10-04" @default.
- W3204693682 modified "2023-10-15" @default.
- W3204693682 title "Antibiotics in the pipeline: a literature review (2017–2020)" @default.
- W3204693682 cites W1538374398 @default.
- W3204693682 cites W1829442556 @default.
- W3204693682 cites W1977536055 @default.
- W3204693682 cites W2019349925 @default.
- W3204693682 cites W2101425637 @default.
- W3204693682 cites W2133406641 @default.
- W3204693682 cites W2139403326 @default.
- W3204693682 cites W2159836772 @default.
- W3204693682 cites W2268368058 @default.
- W3204693682 cites W2484777715 @default.
- W3204693682 cites W2491945327 @default.
- W3204693682 cites W2550643720 @default.
- W3204693682 cites W2604160801 @default.
- W3204693682 cites W2608048982 @default.
- W3204693682 cites W2608065892 @default.
- W3204693682 cites W2695547329 @default.
- W3204693682 cites W2745310222 @default.
- W3204693682 cites W2745860653 @default.
- W3204693682 cites W2751867143 @default.
- W3204693682 cites W2765178452 @default.
- W3204693682 cites W2766703497 @default.
- W3204693682 cites W2772386878 @default.
- W3204693682 cites W2775239537 @default.
- W3204693682 cites W2779019546 @default.
- W3204693682 cites W2782076686 @default.
- W3204693682 cites W2782246563 @default.
- W3204693682 cites W2783987460 @default.
- W3204693682 cites W2790730042 @default.
- W3204693682 cites W2793280651 @default.
- W3204693682 cites W2795093428 @default.
- W3204693682 cites W2795880500 @default.
- W3204693682 cites W2800508719 @default.
- W3204693682 cites W2801017357 @default.
- W3204693682 cites W2804406807 @default.
- W3204693682 cites W2884130512 @default.
- W3204693682 cites W2888126110 @default.
- W3204693682 cites W2895476585 @default.
- W3204693682 cites W2895593384 @default.
- W3204693682 cites W2895787953 @default.
- W3204693682 cites W2897109701 @default.
- W3204693682 cites W2900525970 @default.
- W3204693682 cites W2901178499 @default.
- W3204693682 cites W2902558633 @default.
- W3204693682 cites W2904230285 @default.
- W3204693682 cites W2911821166 @default.
- W3204693682 cites W2912632549 @default.
- W3204693682 cites W2913024914 @default.
- W3204693682 cites W2914722304 @default.
- W3204693682 cites W2915553362 @default.
- W3204693682 cites W2921212199 @default.
- W3204693682 cites W2945385850 @default.
- W3204693682 cites W2950093013 @default.
- W3204693682 cites W2992865737 @default.
- W3204693682 cites W3007177012 @default.
- W3204693682 cites W3007887833 @default.
- W3204693682 cites W3009599329 @default.
- W3204693682 cites W3010816592 @default.
- W3204693682 cites W3013668650 @default.
- W3204693682 cites W3048167711 @default.
- W3204693682 cites W3049761879 @default.
- W3204693682 cites W3092173712 @default.
- W3204693682 cites W3096745875 @default.
- W3204693682 cites W3130451024 @default.
- W3204693682 cites W3131557924 @default.
- W3204693682 cites W3132672963 @default.
- W3204693682 cites W3183344314 @default.
- W3204693682 cites W4235175266 @default.
- W3204693682 doi "https://doi.org/10.1007/s15010-021-01709-3" @default.
- W3204693682 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8488069" @default.
- W3204693682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34606056" @default.
- W3204693682 hasPublicationYear "2021" @default.
- W3204693682 type Work @default.
- W3204693682 sameAs 3204693682 @default.
- W3204693682 citedByCount "31" @default.
- W3204693682 countsByYear W32046936822022 @default.
- W3204693682 countsByYear W32046936822023 @default.
- W3204693682 crossrefType "journal-article" @default.
- W3204693682 hasAuthorship W3204693682A5004324358 @default.
- W3204693682 hasAuthorship W3204693682A5014593593 @default.
- W3204693682 hasAuthorship W3204693682A5014988046 @default.
- W3204693682 hasAuthorship W3204693682A5020602200 @default.
- W3204693682 hasAuthorship W3204693682A5022201674 @default.